Rapid Therapeutic Science Laboratories, Inc. (RTSL)

RTSL Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Mar 31, 2020	Mar 31, 2019
Net Income	0.06	-1.79	-2.87	-2.36	-0.62	-0.35
Depreciation & Amortization	0.02	0.02	0.03	0.11	0.04	-
Other Amortization	0.5	1.76	1.15	-	-	-
Stock-Based Compensation	-0.06	0.02	0.02	0.46	0.18	0.04
Other Operating Activities	-1.02	-1.36	-0.63	-	-	-
Change in Inventory	-	-	-	-0.19	-0.01	-
Change in Accounts Payable	-0.07	0.13	0.1	0.03	0.04	0
Change in Unearned Revenue	-	-	-	-	0.03	-
Change in Other Net Operating Assets	-0	0.07	-0.02	0.07	0.15	0.19
Operating Cash Flow	-0.57	-1.15	-2.21	-1.88	-0.19	-0.11
Capital Expenditures	0.32	-0.04	-0.29	-0.11	-	-
Sale (Purchase) of Intangibles	-	-	-	-	-0.16	-
Investing Cash Flow	0.32	-0.04	-0.29	-0.11	-0.16	-
Long-Term Debt Issued	-	1.29	1.91	-	0.32	0.1
Total Debt Issued	0.39	1.29	1.91	0.42	0.32	0.1
Long-Term Debt Repaid	-	-0.29	-0.3	-	-	-
Total Debt Repaid	-0.29	-0.29	-0.3	-0.15	-	-
Net Debt Issued (Repaid)	0.1	1	1.61	0.27	0.32	0.1
Issuance of Common Stock	0.04	-	0.59	2.18	0.17	-
Other Financing Activities	-	-	-	-0.09	-	-
Financing Cash Flow	0.14	1	2.2	2.36	0.48	0.1
Net Cash Flow	-0.11	-0.19	-0.31	0.37	0.13	-0.01
Free Cash Flow	-0.25	-1.19	-2.5	-1.99	-0.19	-0.11
Free Cash Flow Margin	-	-	-468476.03%	-1417.65%	-2084.95%	-
Free Cash Flow Per Share	-0.03	-0.15	-0.33	-0.30	-0.08	-2.21
Cash Interest Paid	0.05	0.06	-	0.01	-	-
Levered Free Cash Flow	-0.77	-0.24	-0.23	-	0.02	0.02
Unlevered Free Cash Flow	-0.9	-0.82	-0.55	-	0.14	0.13
Change in Net Working Capital	0.89	0.04	-1.05	-	-0.35	-0.2

Source: S&P Capital IQ. Standard template.